Osborne Clarke advises Invicro on acquisition of Imanova
Osborne Clarke has advised leading US-based imaging services company inviCRO, LLC (Invicro) on its acquisition of Imanova Limited, creating a global provider of imaging services and analytics across the entire drug development pipeline.
Founded in 2011 through a unique joint venture between the MRC, Imperial College London, Kings College London and University College London, Imanova is a world leader in the development of novel imaging biomarkers and analysis techniques and their application in clinical academic research and translational drug development.